Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
NMS Labs
AddedFeb 15, 2024
UpdatedJun 18, 2026
NMS Labs

NMS Labs

Series A

NMS Labs: Premier US-based provider of comprehensive laboratory diagnostic and forensic services.

HQ
Horsham, PA, US
Founded
1970
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to advance public health and safety, NMS Labs is a premier provider of comprehensive laboratory diagnostic and forensic services in the United States. The company offers a wide range of testing services, including drug-impaired driving, drugs of abuse, exposure monitoring, newborn toxicology, and postmortem toxicology. NMS Labs serves a diverse clientele, including attorneys, crime laboratories, death investigators, and contract research organizations, aiming to deliver accurate and timely results that support critical decision-making processes.

NMS Labs has garnered notable affiliations with leading experts in forensic science and toxicology. The company has achieved significant milestones, such as becoming a trusted partner for various governmental and private entities in forensic investigations. Through its innovative testing solutions and commitment to quality, NMS Labs has made a substantial impact on public health and safety, contributing to advancements in forensic science and clinical diagnostics.

NMS Labs - Quick Facts

When was NMS Labs founded?

NMS Labs was founded in 1970.

Where is NMS Labs' headquarters located?

NMS Labs' headquarters is located in Horsham, PA, US.

When was NMS Labs' last funding round?

NMS Labs' most recent funding round was for $12.3M (USD) in November 2020.

How much has NMS Labs raised to-date?

As of Nov 4, 2020, NMS Labs has raised a total of $12.3M (USD).

How many employees does NMS Labs have?

NMS Labs has 446 employees as of Feb 4, 2024.

NMS Labs - Classification

Industry
  • Professional Service Companies
Technology
  • Analytics
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Transactional
Customer
  • Enterprise
  • Government
Main Product
  • Laboratory Services
Tags
  • Biotech
NAICS
  • 621000Ambulatory Health Care Services
  • 621500Medical and Diagnostic Laboratories
  • 621510Medical and Diagnostic Laboratories
  • 621511Medical Laboratories
  • 620000Health Care and Social Assistance
SIC
  • 8070Medical And Dental Laboratories
  • 8071Medical Laboratories
  • 8000Health Services
ISIC
  • 7120Technical testing and analysis
Show 9 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541380Testing Laboratories and Services
  • 541000Professional, Scientific, and Technical Services
  • 541300Architectural, Engineering, and Related Services
SIC
  • 8734Testing Laboratories
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified